Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- DEFUSE 3Independent statistical analysis of Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02586415).
- Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358760).
- Delirium Treatment With Acupuncture in Internal Medicine Departments: Complete Statistical AnalysisIndependent statistical analysis of Delirium Treatment With Acupuncture in Internal Medicine Departments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03398928).
- DelishIndependent statistical analysis of Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03207711).
- DELISH R33Independent statistical analysis of (R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DELIVERIndependent statistical analysis of the DELIVER phase 3 trial of dapagliflozin in heart failure with preserved ejection fraction, including its dual primary time-to-event endpoints, Cox models, recurrent-event analysis, KCCQ analysis, safety, and…
- DELIVERIndependent statistical analysis of Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DELIVERIndependent statistical analysis of Isotretinoin for Proliferative Vitreoretinopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01445028).
- Dementia Symptom Management at Home Program: Complete Statistical AnalysisIndependent statistical analysis of Dementia Symptom Management at Home Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255967).
- Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases: Complete Statistical AnalysisIndependent statistical analysis of Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases: primary endpoint results, effect estimate…
- DEP-CIIndependent statistical analysis of Combination Treatment Study for Memory Impairment and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01658228).
- DEPICT 1Independent statistical analysis of Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268214).
- Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System: Complete Statistical AnalysisIndependent statistical analysis of Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DEPO-ABCDIndependent statistical analysis of Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Depression-Diabetes Mechanisms: Urban African Americans: Complete Statistical AnalysisIndependent statistical analysis of Depression-Diabetes Mechanisms: Urban African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00209170).
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: Complete Statistical AnalysisIndependent statistical analysis of Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02061813).
- Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity: Complete Statistical AnalysisIndependent statistical analysis of Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Desaturation Validation of INVSENSOR00006: Complete Statistical AnalysisIndependent statistical analysis of Desaturation Validation of INVSENSOR00006: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435211).
- Desaturation Validation of INVSENSOR00031: Complete Statistical AnalysisIndependent statistical analysis of Desaturation Validation of INVSENSOR00031: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03783780).
- Desaturation Validation of INVSENSOR00037: Complete Statistical AnalysisIndependent statistical analysis of Desaturation Validation of INVSENSOR00037: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04002973).
- Desensitization in Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Desensitization in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00908583).
- Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: Complete Statistical AnalysisIndependent statistical analysis of Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986947).
- Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Design and Usability Testing of a Tailored Intervention About Sleep and Sleep Disorders Among Transportation Workers: Complete Statistical AnalysisIndependent statistical analysis of Design and Usability Testing of a Tailored Intervention About Sleep and Sleep Disorders Among Transportation Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore: Complete Statistical AnalysisIndependent statistical analysis of Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Designing a Mental Health Model for Latina Women: Complete Statistical AnalysisIndependent statistical analysis of Designing a Mental Health Model for Latina Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03901430).
- Desmopressin Acetate 0.2 mg Tablets, Fasting: Complete Statistical AnalysisIndependent statistical analysis of Desmopressin Acetate 0.2 mg Tablets, Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835211).
- DESSOLVE IIIIndependent statistical analysis of Study Comparing the MiStent SES Versus the XIENCE EES Stent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02385279).
- DESTINATIONIndependent statistical analysis of Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DESTINY-Breast04Independent statistical analysis of DESTINY-Breast04, a randomized phase 3 trial of trastuzumab deruxtecan versus investigator's choice for HER2-low breast cancer. Includes the reported progression-free survival analysis, trial design, statistical methodology, interpretation, and…
- DESTINY-Breast06Independent statistical analysis of DESTINY-Breast06 (NCT04494425), a randomized phase 3 trial comparing trastuzumab deruxtecan with investigator's choice chemotherapy in HER2-low, hormone receptor-positive, advanced or metastatic breast cancer.
- DESTINY-LUNG02Independent statistical analysis of Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Detection of Barrett s Esophagus in Patients Without GERD Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Detection of Barrett s Esophagus in Patients Without GERD Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04880044).
- Detection of Graft Versus Host Disease With [18F]F-AraG: Complete Statistical AnalysisIndependent statistical analysis of Detection of Graft Versus Host Disease With [18F]F-AraG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367962).
- Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: Complete Statistical AnalysisIndependent statistical analysis of Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Determining the Potential Benefit of Powered Prostheses: Complete Statistical AnalysisIndependent statistical analysis of Determining the Potential Benefit of Powered Prostheses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02828982).
- DeuceIndependent statistical analysis of Functional Performance of the Journey Deuce Bicompartmental Versus the Genesis II Total Knee System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Developing a Non-invasive Cardiac Functional Health Status Measurement Device: Complete Statistical AnalysisIndependent statistical analysis of Developing a Non-invasive Cardiac Functional Health Status Measurement Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01877343).
- Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): Complete Statistical AnalysisIndependent statistical analysis of Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Developing an Activity Pacing Framework: Feasibility and Acceptability: Complete Statistical AnalysisIndependent statistical analysis of Developing an Activity Pacing Framework: Feasibility and Acceptability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03497585).
- Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Developing an Online Therapeutic Intervention for Chronic Pain in Veterans: Complete Statistical AnalysisIndependent statistical analysis of Developing an Online Therapeutic Intervention for Chronic Pain in Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03655132).
- Developing and Testing a Comprehensive MS Spasticity Management Program: Complete Statistical AnalysisIndependent statistical analysis of Developing and Testing a Comprehensive MS Spasticity Management Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02170779).
- Developing and Validating Fertilit-e: Complete Statistical AnalysisIndependent statistical analysis of Developing and Validating Fertilit-e: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03599661).
- Developing E-liquid Product Standards (Sweet Spot Study): Complete Statistical AnalysisIndependent statistical analysis of Developing E-liquid Product Standards (Sweet Spot Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05864586).